Thu, September 24, 2020
Wed, September 23, 2020
Tue, September 22, 2020

Michael Schmitz Maintained (BPMC) at Strong Buy with Increased Target to $106 on, Sep 23rd, 2020

Michael Schmitz of Guggenheim, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $94 to $106 on, Sep 23rd, 2020.

Michael has made no other calls on BPMC in the last 4 months.



There are 3 other peers that have a rating on BPMC. Out of the 3 peers that are also analyzing BPMC, 0 agree with Michael's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Michael


  • Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $107 on, Monday, July 27th, 2020
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $110 on, Wednesday, July 15th, 2020
  • Konstantinos Aprilakis of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $85 on, Monday, June 8th, 2020